Terms: = Prostate cancer AND TRA AND Prognosis
1 results:
1. Overexpression of the Pluripotent Stem Cell Marker Podocalyxin in prostate cancer.
Heath EI; Heilbrun LK; Smith D; Schopperle WM; Ju Y; Bolton S; Ahmed Q; Sakr WA
Anticancer Res; 2018 Nov; 38(11):6361-6366. PubMed ID: 30396958
[TBL] [Abstract] [Full Text] [Related]
